Navigation Links
Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1/2 Study of MM-111, a Bispecific Antibody to ErbB2/3
Date:7/6/2009

e range of tumor types and we are hopeful this will translate into patient benefit. START and Fox Chase are outstanding cancer research centers and we are excited to be working with leading clinical investigators at both institutions."

Merrimack has developed a broad intellectual property position around its oncology therapeutic portfolio, including its bispecific antibody technology and MM-111. This portfolio includes U.S. and international patent filings relating to compositions of matter and methods of use as well as licensed patents and pending patent applications, trade secrets and proprietary know-how.

About Merrimack
Merrimack Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of novel treatments for cancer and autoimmune disease. Its first two oncology pipeline candidates, MM-121 and MM-111, are currently in Phase 1 clinical development. The Company's proprietary Network Biology discovery platform, developed with the help of leading scientists from MIT and Harvard, enables the high-throughput profiling of protein networks as a basis for improved validation, lead identification and speed in the development of innovative, effective and well tolerated therapeutics. MM-121 and MM-111 are investigational drugs and have not been approved by the U.S. Food and Drug Administration or any international regulatory agency. Merrimack is a privately-held company based in Cambridge, Massachusetts.

Contact:
Kathleen Petrozzelli, Corporate Communications, 617-441-1043, kpetrozzelli(at)merrimackpharma.com     http://www.merrimackpharma.com

Betsy Stevenson, RaymondStevenson Healthcare, 860-984-1424, betsy(at)raymondstevenson.com

###

Read the full story at http://www.prweb.com/relea
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

1

GOOD

Page: 1 2 3 4

Related medicine news :

1. Endo Pharmaceuticals to Announce Second Quarter 2009 Financial Results on July 30, 2009
2. Peregrine Pharmaceuticals Completes Planned Patient Enrollment in Bavituximab Phase I Cancer Trial
3. Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM211, a Novel Product Candidate for the Treatment of Respiratory Diseases
4. Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products
5. Lotus Pharmaceuticals, Inc. Again Awarded GSP Certification
6. Access Pharmaceuticals Announces Commercial Launch of MuGard(TM) in Greece by SpePharm
7. Biostar Pharmaceuticals, Inc. Begins Construction of Raw Material Processing Facility of the Herbal Plantation Base
8. Watson Pharmaceuticals Receives FDA Approval For Generic PLAN B(R)
9. The Crohns & Colitis Foundation and Procter & Gamble Pharmaceuticals Announce 2009 Celebrating UC Success Contest Winners
10. Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Vascular Imaging Applications of Its PS-Targeting Platform
11. DiaGenic to Provide MCI Biomarkers for Merz Pharmaceuticals

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1/2 Study of MM-111, a Bispecific Antibody to ErbB2/3
Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1/2 Study of MM-111, a Bispecific Antibody to ErbB2/3
(Date:11/26/2009)...heavy can lead to strains or worse , , T...nothing wrong with stuffing your turkey full to bu...g with your suitcase as you pack for holiday trips...8 in U.S. hospital emergency rooms, doctors, offic...ge-related injuries, such as muscle strains, pulls...
(Date:11/26/2009)...arch Triangle Dental (RTDental), a leading dental ...nounced the expansion of its services to include L... Macmillan. , Durham, ...to announce that Dr. Doug Macmillan, an experience...ional advanced training seminar. RTDental’s...
(Date:11/25/2009)...PRNewswire/--TheBartleHallConventionCenterwilltemp...9-10,whenKansasCityhoststhelatestinaseriesofmassiv...niceventhasthepotentialtobethebiggestoneyet,becaus...nweekdaysinsteadofoveraweekend,"SheriWood,executiv...ntoftheNationalAssociationofFreeClinics(NAFC). ,...
(Date:11/25/2009)...5/PRNewswire/--Thanksgivingmealswillbedeliveredtoa...eachareathankstoFaithInAction/VolunteerActionforAg...isionofSCANHealthPlan.Formorethan17yearstheseorgan...armThanksgivingmealstoseniorsinneedinLongBeach,Lak...ndingcities. ,, "Ourwarmholidaymealsaredelivere...
(Date:11/25/2009)...ments,Business,andPressJoinEfforttoEducate ,, ...gain,theNationalBipolarFoundationandtheMedicAlertF...ilStable"program,whichisnowbeingwidelyacceptedasap...,theNationalBipolarFoundationreceivedaproclamation...t.GovernorofLouisianaMitchLandrieu.TheNationalBipo...
Breaking Medicine News(10 mins):Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3
...strogens in the early stages of the development of...cited by the scientists for the development of the... The study, done in an animal model, also demons...(xenoestrogens) are widespread in the environment....
...omen, men are more interested in getting married a...ps as women, according to a study, which looks int... women, who aged between 15 to 44, were surveyed w...gency study involving men since 1973. Nearly 6...
...ve found that Nepali rhesus is by all means a suit...ch is currently been used in biomedical research. ...age the prevailing shortage of laboratory animals ... headed by Randall Kyes of the University of Washi...
...y conducted by UT Southwestern Medical Center, has...s about the television's potential danger. // It h...t that is harmful but the physical danger of falli...pling over, usually because of climbing toddlers o...
...ng the introduction of a UN AIDS report, UN offici...id spread of HIV/AIDS in Myanmar and Vietnam // , ...ibility to treatment. Even Thailand, which w...e is a risk of history being repeated. Patric...
...ces in state-run hospitals across the country were...20 days of anti-quota protests following a directi...n premier health institutions like AIIMS, MAMC, La...pitals in West Bengal, Karnataka, Uttar Pradesh, P...
Other Medicine News:Health News:Prostate Cancer Risk Linked To Early Estrogen Exposure 2Health News:Nepali Rhesus May be Used as an Alternate for HIV/AIDS Research 2Health News:Nepali Rhesus May be Used as an Alternate for HIV/AIDS Research 3Health News:Adults Needs to be Educated About the Dangers of Elevated TVs 2
(Date:11/24/2009)..., WOODCLIFFLAKE,N.J.andNEWYORK,Nov.24/PRNewswire/-...oodandDrugAdministration(FDA)hasacceptedforreviewE...pt®(donepezilHClextendedrelease)tabletsforthe...Thisnewhigherdoseformulationcontains23mgofdonepezi...verysystemthatallowsforgradualreleaseofthedrug.The...
(Date:11/24/2009)..., PLEASANTON,Calif.,Nov.24/PRNewswire-FirstCall/--...evice-basedmechanicalcirculatorysupporttherapiesto...twillbeparticipatinginthe21stAnnualPiperJaffrayHea....Smith,executivevicepresidentandchieffinancialoffi...0a.m.,EasternStandardTime(5:30a.m.,PacificStandard...
(Date:11/24/2009)..., STAMFORD,Conn.,Nov.24/PRNewswire/--ZargisMedical...spin-offfromSiemensCorporateResearch(NYSE: SI ),to...edontheNovember24,2009episodeofCBS, TheEarlyShow d...Science magazine,reviewedfivewinningproductsfromth...TheEarlyShow isawidely-viewedtelevisionmorningnews...
Breaking Medicine Technology:FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Zargis Cardioscan(TM) Featured on The Early Show on CBS 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 3Eli Lilly and Company Opens Eco Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation 5848 1Eli Lilly and Company Opens Eco Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation 5848 2Eli Lilly and Company Opens Eco Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation 5848 3Eli Lilly and Company Opens Eco Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation 5848 4Eli Lilly and Company Opens Eco Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation 5848 5Patent Attorneys McDaniel and Stipkala to Confer at Summit November 4 2009 60349 1House Healthcare Bill 3A Government Run Plan Other Key Provisions Undermine Goals of Access and Affordability 60346 1House Healthcare Bill 3A Government Run Plan Other Key Provisions Undermine Goals of Access and Affordability 60346 2House Healthcare Bill 3A Government Run Plan Other Key Provisions Undermine Goals of Access and Affordability 60346 3
... Auto Suture™ VERSAPORT™ PLUS RPF troc...5 mm-11 mm, 5 mm-12 mm, and 10 mm-15 mm sizes with...T™ PLUS RPF trocar has a sharp pyramidal tip...e space in the abdominal or chest cavity, the shie...
SURGINEEDLE™ (Single Use Pneumoperitoneum Needles)
... complete line of Surgical Access ...unlike any tr...; trocar system is actually four systems in one d...d clinically adaptive to all of your needs., ,By ...lating tip styles, OnePort™ can effectively ...
... complete line of Surgical Access ...unlike any tr...; trocar system is actually four systems in one d...d clinically adaptive to all of your needs., ,By ...lating tip styles, OnePort™ can effectively ...
Medicine Products: